Saeed Dabestani (@drdabestani) 's Twitter Profile
Saeed Dabestani

@drdabestani

Consultant Urologist, M.D. Ph.D.
Associate Professor.
@Uroweb EAU RCC GL Panel member.
RFL Renal Cancer πŸ€– Fellow Alumni.
πŸ‘¨β€πŸ‘§β€πŸ‘§,🀹🏽, πŸ‘¨β€πŸ”¬
Views my own.

ID: 2439970951

calendar_today12-04-2014 12:38:52

680 Tweet

382 Followers

322 Following

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

πŸ”₯ BREAKING: Our #EAU25 game changers are here! We are happy to announce the ground-breaking studies that will be presented in Madrid. Visit: scientific-programme.uroweb.org and πŸ”Ž search for β€˜game changers’ to view each day’s session. See you in Madrid!

π™π™žπ™˜π™˜π™–π™§π™™π™€ π˜½π™šπ™§π™©π™€π™‘π™€ MD PhD (@ricbertolo) 's Twitter Profile Photo

Plenary presentation by Saeed Dabestani - Game-Changer session: results of AURORAX-0087A trial cohort 1 are out! Urine #GAGome Score is a promising #biomarker for early detection of #ccRCC #recurrence. Strong 97% NPV - if test negative, recurrence ruled out. Finally, something is

Plenary presentation by <a href="/DrDabestani/">Saeed Dabestani</a> - Game-Changer session: results of AURORAX-0087A trial cohort 1 are out!

Urine #GAGome Score is a promising #biomarker for early detection of #ccRCC #recurrence.

Strong 97% NPV - if test negative, recurrence ruled out.

Finally, something is
European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

πŸ“ΊEAU25: EAUTV on AURORAX 0087A study UROONCO RCC chief editor Dr. Carmen Mir talks to Assoc. Prof. Saeed Dabestani on the AURORAX 0087A study. ▢️ Watch the conversation here: eaucongress.uroweb.org/eau25-eautv-on…

Inside Precision Medicine (@inside_pm) 's Twitter Profile Photo

A Urine-Based Biomarker for Early Kidney Cancer Recurrence Detection The study aimed to determine how to effectively monitor kidney cancer patients for recurrence without excessive reliance on imaging. Lund University European Association of Urology (EAU) Saeed Dabestani hubs.li/Q03dvXC70

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

7 robotic surgical platforms. Live cases. The best in robotic urology. Welcome to ERUS25! πŸ“ London, 10-12 September, 2025 πŸ“ŒRegistration & abstract submission now open! πŸš€ Live surgery, case discussions, industry sessions and more! πŸ”— Join us: erus25.org

7 robotic surgical platforms. Live cases. The best in robotic urology.  Welcome to ERUS25!

πŸ“ London, 10-12 September, 2025
πŸ“ŒRegistration &amp; abstract submission now open!

πŸš€ Live surgery, case discussions, industry sessions and more!

πŸ”— Join us: erus25.org
Ravi Barod (@ravibarodurol) 's Twitter Profile Photo

our excellent fellowship at the specialist centre for kidney cancer Royal Free London is open BAUS The Royal College of Surgeons of England ERUS Robotic Urology accredited 450 nephrectomies/y oct 2026 start apply here to join our friendly team πŸ˜ŽπŸ‘‡πŸ½ jobs.nhs.uk/candidate/joba…

our excellent fellowship at the specialist centre for kidney cancer <a href="/RoyalFreeNHS/">Royal Free London</a> is open

<a href="/BAUSurology/">BAUS</a> <a href="/RCSnews/">The Royal College of Surgeons of England</a> <a href="/ERUSrobotics/">ERUS Robotic Urology</a> accredited

450 nephrectomies/y

oct 2026 start

apply here to join our friendly team πŸ˜ŽπŸ‘‡πŸ½

jobs.nhs.uk/candidate/joba…
π™π™žπ™˜π™˜π™–π™§π™™π™€ π˜½π™šπ™§π™©π™€π™‘π™€ MD PhD (@ricbertolo) 's Twitter Profile Photo

Out in European Urology Open Science our global 🌎 Delphi consensus about #tumor #rupture during #robotic #partialnephrectomy! This consensus forms a basis for future #research on tumor rupture in #RAPN, emphasizing need for #standardized #definitions and uniform #management strategies.

Out in <a href="/EurUrolOpen/">European Urology Open Science</a> our global 🌎 Delphi consensus about #tumor #rupture during #robotic #partialnephrectomy!

This consensus forms a basis for future #research on tumor rupture in #RAPN, emphasizing need for #standardized #definitions and uniform #management strategies.
Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

TAR-200 in BCG-unresponsive NMIBC #AUA25 β€’82% CR rate at anytime β€’53% β‰₯12-mo durability CR β€’86.6% cystectomy-free at 12 mo If you compare to other available tx➑️➑️At 12 mo duration ‼️TAR-200 53% β‰₯12-mo DOR vs Adstiladrin 46%, Anktiva+BCG 58%

TAR-200 in BCG-unresponsive NMIBC #AUA25
β€’82% CR rate at anytime 
β€’53% β‰₯12-mo durability CR
β€’86.6% cystectomy-free at 12 mo
If you compare to other available tx➑️➑️At 12 mo duration 
‼️TAR-200 53% β‰₯12-mo DOR vs Adstiladrin 46%, Anktiva+BCG 58%
ecancer (@ecancer) 's Twitter Profile Photo

Study introducing urine urine-based diagnostic test that measures GAGs to detect ccRCC recurrence. Test shows promise in reducing unnecessary scans and health care costs. Full interview with Dr Dabestani of Lund University πŸ‘‰ bit.ly/3EjGhZx Saeed Dabestani #EAU25

Jeremy Teoh (@jteoh_hk) 's Twitter Profile Photo

We did it!! I am really honoured to lead this important FIH study! A novel transurethral robotic system that can make ERBT much easier, and hopefully we can generalize the technique to every urologist globally. A better surgery will lead to better outcomes!! 🌎 #UroSoMe

We did it!! I am really honoured to lead this important FIH study! A novel transurethral robotic system that can make ERBT much easier, and hopefully we can generalize the technique to every urologist globally. A better surgery will lead to better outcomes!! 🌎 #UroSoMe
Saeed Dabestani (@drdabestani) 's Twitter Profile Photo

Spoke at #BeGUS2025 on updates in kidney & bladder cancer, featuring results from AURORAX-0087A Coh1 on #GAGomescore for ccRCC recurrence detection. Insightful panel discussion indeed. Thanks you organizers incl Eduard Roussel & steven joniau for the invite.

Spoke at #BeGUS2025 on updates  in kidney &amp; bladder cancer, featuring results from AURORAX-0087A Coh1 on #GAGomescore for ccRCC recurrence detection.

Insightful panel discussion indeed.

Thanks you organizers incl <a href="/Eduardrssl/">Eduard Roussel</a> &amp; <a href="/joniau/">steven joniau</a> for the invite.
Tom Powles (@tompowles1) 's Twitter Profile Photo

Ipi/nivo vs VEGF TKI in non-clear cell RCC Annals of Oncology The 1st randomised IO data in these cancers, establishing IO. It’s +ve but not overwhelming. Some minor design issues too.VEGF/PD1 combos are probably better, but those studies were not randomised sciencedirect.com/science/articl…

Ipi/nivo vs VEGF TKI in non-clear cell RCC <a href="/Annals_Oncology/">Annals of Oncology</a> The 1st randomised IO data in these cancers, establishing IO. It’s +ve but not overwhelming. Some minor design issues too.VEGF/PD1 combos are probably better, but those studies were not randomised sciencedirect.com/science/articl…